GSA Capital Partners LLP Has $1.26 Million Stock Holdings in Hill-Rom Holdings, Inc. (NYSE:HRC)
GSA Capital Partners LLP lifted its position in shares of Hill-Rom Holdings, Inc. (NYSE:HRC) by 341.1% during the 2nd quarter, Holdings Channel reports. The firm owned 12,025 shares of the medical technology company’s stock after purchasing an additional 9,299 shares during the quarter. GSA Capital Partners LLP’s holdings in Hill-Rom were worth $1,258,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors have also recently added to or reduced their stakes in HRC. FMR LLC increased its stake in shares of Hill-Rom by 17.8% during the 1st quarter. FMR LLC now owns 1,870,034 shares of the medical technology company’s stock worth $197,962,000 after purchasing an additional 282,069 shares during the last quarter. First Trust Advisors LP increased its stake in shares of Hill-Rom by 156.7% during the 1st quarter. First Trust Advisors LP now owns 346,685 shares of the medical technology company’s stock worth $36,700,000 after purchasing an additional 211,643 shares during the last quarter. Bank of Montreal Can increased its stake in shares of Hill-Rom by 5.0% during the 1st quarter. Bank of Montreal Can now owns 1,724,410 shares of the medical technology company’s stock worth $182,547,000 after purchasing an additional 81,956 shares during the last quarter. Strs Ohio increased its stake in shares of Hill-Rom by 87.2% during the 2nd quarter. Strs Ohio now owns 168,941 shares of the medical technology company’s stock worth $17,674,000 after purchasing an additional 78,675 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale increased its stake in shares of Hill-Rom by 2,111.7% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 61,198 shares of the medical technology company’s stock worth $6,384,000 after purchasing an additional 58,431 shares during the last quarter. Institutional investors own 81.86% of the company’s stock.
In other Hill-Rom news, SVP Paul Sherwood Johnson sold 6,470 shares of the stock in a transaction that occurred on Wednesday, August 14th. The shares were sold at an average price of $104.26, for a total transaction of $674,562.20. Following the transaction, the senior vice president now owns 8,215 shares in the company, valued at approximately $856,495.90. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Deborah Rasin sold 5,500 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $103.00, for a total transaction of $566,500.00. Following the transaction, the senior vice president now owns 20,939 shares in the company, valued at approximately $2,156,717. The disclosure for this sale can be found here. Corporate insiders own 0.73% of the company’s stock.
HRC traded down $1.40 on Friday, reaching $104.30. The company had a trading volume of 431,896 shares, compared to its average volume of 467,783. Hill-Rom Holdings, Inc. has a fifty-two week low of $81.82 and a fifty-two week high of $109.18. The stock has a market cap of $7.06 billion, a P/E ratio of 21.96, a P/E/G ratio of 2.09 and a beta of 0.90. The company’s fifty day moving average is $105.57 and its 200 day moving average is $103.19. The company has a debt-to-equity ratio of 1.12, a quick ratio of 1.14 and a current ratio of 1.51.
Hill-Rom (NYSE:HRC) last announced its quarterly earnings results on Friday, August 2nd. The medical technology company reported $1.23 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.02. Hill-Rom had a net margin of 7.45% and a return on equity of 21.26%. The business had revenue of $726.80 million for the quarter, compared to analyst estimates of $718.08 million. During the same quarter in the prior year, the business earned $1.15 EPS. Hill-Rom’s quarterly revenue was up 2.6% on a year-over-year basis. On average, sell-side analysts expect that Hill-Rom Holdings, Inc. will post 5.05 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Friday, September 20th will be given a dividend of $0.21 per share. The ex-dividend date of this dividend is Thursday, September 19th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.81%. Hill-Rom’s payout ratio is presently 17.68%.
Hill-Rom Holdings, Inc operates as a medical technology company worldwide. It operates in three segments: Patient Support Systems, Front Line Care, and Surgical Solutions. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other patient mobility devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions; and medical equipment management services, as well as sells equipment service contracts for its capital equipment.
Further Reading: Bond
Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings, Inc. (NYSE:HRC).
Receive News & Ratings for Hill-Rom Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom and related companies with MarketBeat.com's FREE daily email newsletter.